利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

18 条记录 (耗时 0.018 秒)

    Long latency protocol for hard disk controller interface
    5.
    发明授权
    Long latency protocol for hard disk controller interface 有权
    用于硬盘控制器接口的长延迟协议

    公开(公告)号：US08214719B1

    公开(公告)日：2012-07-03

    申请号：US12181172

    申请日：2008-07-28

    申请人： Hongying Sheng ,  Job Lam ,  Kai-Chuan Chang ,  Jianke Li

    发明人： Hongying Sheng ,  Job Lam ,  Kai-Chuan Chang ,  Jianke Li

    IPC分类号： G06F11/00

    CPC分类号： G06F11/073 ,  G06F11/0745 ,  G06F11/0751

    摘要： Some of the embodiments of the present disclosure provide a method comprising receiving a stream of codewords from a hard disk controller (HDC), receiving a write gate signal, the write gate signal configured to request a read/write (R/W) channel to write at least a first part of the stream of codewords to a media, and receiving a symbol count signal indicating a number of symbols in the first part of the received stream of codewords. Other embodiments are also described and claimed.

    摘要翻译： 本公开的一些实施例提供了一种方法，包括从硬盘控制器（HDC）接收码字流，接收写入门信号，写入门信号被配置为请求读/写（R / W）信道 将码字流的至少第一部分写入介质，以及接收指示所接收的码字流的第一部分中的符号数量的符号计数信号。 还描述和要求保护其他实施例。

    Glucagon receptor antagonists, preparation and therapeutic uses
    9.
    发明授权
    Glucagon receptor antagonists, preparation and therapeutic uses 有权
    胰高血糖素受体拮抗剂，制剂和治疗用途

    公开(公告)号：US07863329B2

    公开(公告)日：2011-01-04

    申请号：US12093486

    申请日：2006-11-14

    申请人： Jianke Li ,  Guoxin Zhu

    发明人： Jianke Li ,  Guoxin Zhu

    IPC分类号： A61K31/166 ,  C07C229/28

    CPC分类号： C07C233/83

    摘要： The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like.

    摘要翻译： 本发明公开了具有胰高血糖素受体拮抗剂或反向激动剂活性的新颖的式I化合物或其药学上可接受的盐，以及制备这些化合物的方法。 在另一个实施方案中，本发明公开了包含式I化合物的药物组合物以及使用它们治疗糖尿病和其它与胰高血糖素相关的代谢紊乱等的方法。

    GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES
    10.
    发明申请
    GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES 失效
    GLUCAGON受体拮抗剂，制剂和治疗用途

    公开(公告)号：US20090156655A1

    公开(公告)日：2009-06-18

    申请号：US12093601

    申请日：2006-11-16

    申请人： Scott Eugene Conner ,  Philip Arthur Hipskind ,  Jianke Li ,  Guoxin Zhu

    发明人： Scott Eugene Conner ,  Philip Arthur Hipskind ,  Jianke Li ,  Guoxin Zhu

    IPC分类号： A61K31/41 ,  C07D257/06 ,  A61P3/10

    CPC分类号： C07D257/06 ,  C07D257/04

    摘要： The present invention discloses novel compounds of Formula (I), or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like.

    摘要翻译： 本发明公开了具有胰高血糖素受体拮抗剂或反向激动剂活性的式（I）的新化合物或其药学上可接受的盐，以及制备这些化合物的方法。 在另一个实施方案中，本发明公开了包含式（I）化合物的药物组合物以及使用它们治疗糖尿病和其它与胰高血糖素相关的代谢紊乱等的方法。